Ex Parte Zasloff et al - Page 3


              Appeal No. 2007-0055                                                                 Page 3                
              Application No. 10/053,299                                                                                 

                     A) from about 0.001 to about 99% by weight of an amino acid component                               
                     selected from the group consisting of at least one of the following: L(+)                           
                     isoleucine, DL-isoleucine, D(-)-allo-isoleucine, L(+)-allo-isoleucine, and active                   
                     analogs of isoleucine;                                                                              
                     B) at least one additional pharmacologically active substance selected from the                     
                     group consisting of a fluoride, xylitol, an antibody, an anti-microbial agent, zinc                 
                     ions, a decongestant, an anesthetic, an anti-oxidant, a vitamin, a microbial                        
                     substance, a pre-biotic material, folic acid, echinacea, peppermint oil or extract,                 
                     menthol, quassia, bistort, ginger, angelica, bayberry, chamomile, fish oil, or                      
                     fractionated fish oil, a fatty acid, fiber, flaxseed, a plant extract, garlic or garlic             
                     extract, calcium, stannol esters, lutein, zeaxanthin, cryptoxanthin, isolflavone, an                
                     anti-inflammatory compound, an antifungal agent, and a food product; and                            
                     optionally,                                                                                         
                     C) pharmacologically acceptable carrier materials and/or excipients.                                
                     Claim 1 requires that the “amino acid component” is “selected from the group                        
              consisting of” isoleucine stereoisomers and active analogs of isoleucine.  “Transitional                   
              phrases, such as ‘comprising,’ ‘consisting of,’ and ‘consisting essentially of,’ are terms                 
              of art in patent law that ‘define the scope of the claim with respect to what unrecited                    
              additional components or steps, if any, are excluded from the scope of the claim.’                         
              MPEP §2111.03; accord Vehicular Techs. Corp., 212 F.3d at 1382-83. The phrase                              
              ‘consisting of’ signifies restriction and exclusion of unrecited steps or components.                      
              MPEP §2111.03.”  Conoco Inc. v. Energy & Environmental International LC, 460 F.3d                          
              1349, 1360, 79 USPQ2d 1801, 1808-09 (Fed. Cir. 2006).  Here, the phrase “consisting                        
              of” refers to the members of the group which define the amino acid component.                              
              Accordingly, we construe “consisting of” to limit the amino acid component to only those                   
              compounds specifically recited in the group (i.e., isoleucines), and to exclude the                        
              presence of other amino acid components.  This construction applies to claims 11, 18,                      
              and 32 in which the phrase is also recited.                                                                





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next

Last modified: September 9, 2013